Zoetis (ZTS) Confirms Bill Ackman Call; No Comment on Details of Conversation

Zoetis (NYSE: ZTS) acknowledged that the company received a call from Bill Ackman of Pershing Square indicating that the firm has made an investment in Zoetis. Zoetis declined to comment on details of that conversation.

"We are preparing for our upcoming Investor Day on Tuesday, Nov. 18, and we look forward to sharing more details about the company’s business model and growth strategies with the investment community at that time," company spokesperson Bill Price said in an e-mail to StreetInsider.com.

Shares of Zoetis shot up nearly 9% Tuesday afternoon following a Wall Street Journal story highlighting the Ackman stake. The Journal suggested Ackman took a roughly $2 billion stake in the company. Ackman may push it to sell itself to a large drug maker like Valeant Pharma (NYSE: VRX), which he has unsuccessfully tried to merge with Allergan (NYSE: AGN).

You May Also Be Interested In

• Ancora pressures H.B. Fuller board to explore strategic alternatives
• Nscale raises $3.36bn in convertible notes led by Third Point
• U.S. Negotiations In New York Have Moved Beyond Initial Diplomatic Contacts Into A More Detailed Technical Phase - Al Jazeera